The Tokyo Stock Exchange lost ground Monday at the start of the session, in the wake of losses last Friday on Wall Street, which had been depressed by disappointing US macroeconomic indicators.
The flagship Nikkei index, which had appreciated by more than 3.2% on Friday, fell by 1.32% to 26,732.00 points around 0045 GMT and the broader Topix index dropped 0.92% to 1,880.64 points.
Retail sales in the United States in September were slightly below expectations, and a US consumer confidence index showed that they expected high inflation for a long time, despite already strong efforts by the US Federal Reserve (Fed ) to slow the rise in prices.
On the side of values
TAKEDA: the dengue fever vaccine from the Japanese pharmaceutical group Takeda (-0.75% to 3,799 yen) passed an important milestone for its marketing in Europe on Friday, having received a positive opinion from the Committee for Medicinal Products for Human Use ( CHMP), thus paving the way for its marketing authorization by the European Medicines Agency within a few months.
Dengue fever is a very widespread virus in hot countries, causing several hundred million infections and 500,000 hospitalizations per year worldwide, according to studies cited by Takeda. Already approved in Indonesia, its Qdenga vaccine (TAK-003) should be a serious rival to the only other vaccine currently available once morest dengue fever, Dengvaxia from the French group Sanofi, which has suffered from controversy.
On the side of currencies and oil
The yen regained a tiny bit of ground once morest the dollar, following falling to a new low once morest the greenback since 1990 on Friday. .
The euro rose to 144.70 yen once morest 144.53 yen at the end of last week, and the European currency also appreciated slightly once morest the dollar, at the rate of one euro for 0.9746 dollar once morest 0.9721 dollar Friday.
On the oil market, the barrel of American WTI gained 0.95% to 86.42 dollars around 00:30 GMT and the barrel of Brent from the North Sea gained 1% to 92.55 dollars.
etb/jnd
